Exo Secures $11.6 Million Gates Foundation Grant for AI-Powered Ultrasound

Exo landed an $11.6 million Gates Foundation grant to build an affordable handheld ultrasound with on-device AI for frontline health workers in low- and middle-income countries.

Key Takeaways

  • Exo received an $11.6 million grant from the Gates Foundation, announced November 19, 2026, to develop an affordable handheld ultrasound for frontline health workers.
  • This is philanthropic grant funding, not an equity round, and sits on top of roughly $428 million Exo has raised across ten prior financing rounds, including a $220 million Series C in 2021.
  • Exo's devices pair proprietary piezoelectric silicon imaging hardware with on-device AI that works without an internet connection.
  • Competitor Butterfly Network received a similar $5 million Gates Foundation grant in 2022 for maternal and fetal health imaging in low-resource settings.
  • The grant targets a new, lower-cost device variant for frontline workers without specialized ultrasound training, separate from Exo's existing commercial product line.

Exo has secured an $11.6 million grant from the Gates Foundation, announced November 19, to develop an affordable, multipurpose handheld ultrasound system for frontline health workers in low- and middle-income countries. The grant, reported by Citybiz, is philanthropic funding rather than venture capital, and comes on top of roughly $428 million the company has raised across ten prior financing rounds.

What Exo builds

Exo makes handheld ultrasound devices built around proprietary piezoelectric silicon imaging chips paired with on-device artificial intelligence. The AI runs locally on the handheld unit rather than in the cloud, guiding users through image acquisition and helping interpret scans in real time — a design choice that matters in regions where internet connectivity is unreliable or absent. CEO Sandeep Akkaraju said the approach is meant to make ultrasound "more affordable and easier for frontline healthcare workers to use," even without specialized sonography training.

That focus on untrained operators sets Exo's grant-funded project apart from its existing commercial product line, which has targeted hospitals and clinics in wealthier markets since the company's $220 million Series C in 2021.

How the money will be used

The Gates Foundation grant is earmarked specifically for next-generation imaging technology aimed at closing diagnostic gaps tied to equipment cost, specialist shortages, procedural complexity and spotty connectivity — all barriers that have kept ultrasound largely out of reach for frontline clinics in poorer countries. Rather than funding sales expansion, the grant is structured as development money for a stripped-down, lower-cost device variant suited to that market.

Competitors and how this compares

Exo's closest rival in handheld, AI-guided ultrasound is Butterfly Network, which received its own $5 million Gates Foundation grant in 2022 for maternal and fetal health work in low-resource settings. The parallel grants suggest the Gates Foundation sees AI-guided point-of-care ultrasound as one of the more promising near-term tools for expanding diagnostic imaging in places that will never have a radiology department, rather than betting on a single vendor. Exo's $428 million in prior venture funding dwarfs the size of this grant, underscoring that the money here is about product adaptation for a new market segment, not a funding lifeline.

What to watch next

The near-term question is how quickly Exo can get a lower-cost, offline-capable device variant into the hands of community health workers, and whether the Gates Foundation's involvement helps it secure distribution through public health systems in target countries. Expect comparisons to Butterfly Network's grant-funded maternal health work to sharpen as both companies report results from their respective low-resource deployments.

Category: Funding & Investments

Tags: Exo AI ultrasound Gates Foundation point-of-care ultrasound Butterfly Network global health

Related Articles

Frequently Asked Questions

How much did Exo receive from the Gates Foundation?

Exo received an $11.6 million grant, announced November 19, 2026, to develop an affordable AI-powered handheld ultrasound for frontline health workers in low- and middle-income countries.

Is the Gates Foundation money a funding round?

No. It is a philanthropic grant, not venture capital, and is separate from the roughly $428 million Exo has raised across ten equity financing rounds, including a $220 million Series C in 2021.

What makes Exo's ultrasound different?

It combines proprietary piezoelectric silicon imaging hardware with AI that runs on the device itself rather than in the cloud, so it can guide scans and interpretation without an internet connection.

Who is Exo's main competitor?

Butterfly Network is Exo's closest rival in handheld, AI-guided ultrasound and received its own $5 million Gates Foundation grant in 2022 for maternal and fetal health work.

Who leads Exo?

Sandeep Akkaraju is CEO of Exo.